Emanuela Risi

1.1k total citations
39 papers, 673 citations indexed

About

Emanuela Risi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Emanuela Risi has authored 39 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Emanuela Risi's work include Advanced Breast Cancer Therapies (19 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Genomics and Diagnostics (8 papers). Emanuela Risi is often cited by papers focused on Advanced Breast Cancer Therapies (19 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Genomics and Diagnostics (8 papers). Emanuela Risi collaborates with scholars based in Italy, Switzerland and United States. Emanuela Risi's co-authors include Angelo Di Leo, Luca Malorni, Ilenia Migliaccio, Laura Biganzoli, Amelia McCartney, Matteo Benelli, Martina Bonechi, Chiara Biagioni, Irene De Santo and Francesca De Luca and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Emanuela Risi

37 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emanuela Risi Italy	15	411	378	238	178	86	39	673
Rana Sullivan United States	10	259 0.6×	323 0.9×	349 1.5×	86 0.5×	35 0.4×	19	643
Maria Thadani‐Mulero United States	7	203 0.5×	521 1.4×	307 1.3×	255 1.4×	40 0.5×	11	797
Lavina Bharwani Singapore	9	491 1.2×	179 0.5×	356 1.5×	149 0.8×	44 0.5×	13	861
Anantbhushan Ranade India	11	557 1.4×	286 0.8×	228 1.0×	121 0.7×	84 1.0×	32	795
Helen Musgrove United Kingdom	6	415 1.0×	289 0.8×	441 1.9×	158 0.9×	68 0.8×	7	852
Maria Rosa Cappelletti Italy	13	312 0.8×	251 0.7×	213 0.9×	239 1.3×	29 0.3×	32	635
Aurelio Castrellon United States	12	429 1.0×	392 1.0×	102 0.4×	210 1.2×	125 1.5×	34	655
Ilana Schlam United States	11	324 0.8×	142 0.4×	162 0.7×	93 0.5×	53 0.6×	41	535
Shinichiro Ryuge Japan	18	347 0.8×	239 0.6×	417 1.8×	137 0.8×	15 0.2×	36	738
Hideyuki Abe Japan	16	246 0.6×	227 0.6×	362 1.5×	154 0.9×	27 0.3×	39	739

Countries citing papers authored by Emanuela Risi

Since Specialization

Citations

This map shows the geographic impact of Emanuela Risi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Risi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Risi more than expected).

Fields of papers citing papers by Emanuela Risi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Risi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Risi. The network helps show where Emanuela Risi may publish in the future.

Co-authorship network of co-authors of Emanuela Risi

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Risi. A scholar is included among the top collaborators of Emanuela Risi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Risi. Emanuela Risi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galardi, Francesca, Massimo De Paoli, Dario Romagnoli, et al.. (2025). 52P Dynamics of ctDNA and serum thymidine kinase activity in patients with ER+/HER2- metastatic breast cancer receiving abemaciclib vs palbociclib or ribociclib: Early results of the TIRESIAS trial. ESMO Open. 10. 104606–104606.

Migliaccio, Ilenia, Dario Romagnoli, Francesca Galardi, et al.. (2024). Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial. JCO Precision Oncology. 8(8). e2300285–e2300285. 4 indexed citations

Biganzoli, Laura, Emanuela Risi, Elizabeth Bergsten-Nordström, Matti Aapro, & Étienne Brain. (2023). IN34 OPTIMAL MANAGEMENT OF AN OLDER FRAIL PATIENT WITH ADVANCED BREAST CANCER. The Breast. 71. S26–S27.

Benelli, Matteo, Antonio Nardone, Francesca Galardi, et al.. (2023). 2272P Minimal DNA-methylation (DNAm) signatures for non-invasive tumor-agnostic estimation of tumor content (TC) and molecular subtype in patients (pts) with metastatic breast cancer (mBC). Annals of Oncology. 34. S1166–S1166. 1 indexed citations

Migliaccio, Ilenia, Emanuela Risi, Chiara Biagioni, et al.. (2022). PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer. npj Breast Cancer. 8(1). 24–24. 10 indexed citations

Risi, Emanuela, C. Lisanti, Alessia Vignoli, et al.. (2022). Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients. Translational Oncology. 27. 101585–101585. 2 indexed citations

Vignoli, Alessia, Emanuela Risi, Amelia McCartney, et al.. (2021). Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer. International Journal of Molecular Sciences. 22(9). 4687–4687. 28 indexed citations

Galardi, Francesca, Francesca De Luca, Chiara Biagioni, et al.. (2021). Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial. Breast Cancer Research. 23(1). 38–38. 25 indexed citations

McCartney, Amelia, Martina Bonechi, Francesca De Luca, et al.. (2020). Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial. Clinical Cancer Research. 26(9). 2131–2139. 37 indexed citations

10.

McCartney, Amelia, Alessia Vignoli, Leonardo Tenori, et al.. (2019). Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification. npj Breast Cancer. 5(1). 26–26. 14 indexed citations

11.

Rossi, Lorenzo, Chiara Biagioni, Amelia McCartney, et al.. (2019). Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial. Breast Cancer Research. 21(1). 71–71. 20 indexed citations

12.

Rossi, Lorenzo, Amelia McCartney, Emanuela Risi, et al.. (2019). Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer. Clinical Breast Cancer. 19(6). 392–398. 11 indexed citations

13.

Rossi, Lorenzo, Amelia McCartney, Irene De Santo, et al.. (2019). The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise review. Cancer Treatment Reviews. 74. 29–34. 15 indexed citations

14.

Rossi, Lorenzo, Chiara Biagioni, Amelia McCartney, et al.. (2018). Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the Literature. Anticancer Research. 38(8). 4839–4845. 7 indexed citations

15.

Guarducci, Cristina, Martina Bonechi, Giulia Boccalini, et al.. (2017). Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response. Breast Care. 12(5). 304–308. 56 indexed citations

16.

Grande, Roberta, Clara Natoli, Ida Pavese, et al.. (2016). Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis. PLoS ONE. 11(7). e0157751–e0157751. 14 indexed citations

17.

Lambertini, Matteo, Arlindo R. Ferreira, Francesca Poggio, et al.. (2015). Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study. The Oncologist. 20(8). 880–889. 22 indexed citations

18.

Risi, Emanuela, Roberto Iacovelli, Amelia Altavilla, et al.. (2013). Clinical and Pathological Features of Primary Neuroectodermal Tumor/Ewing Sarcoma of the Kidney. Urology. 82(2). 382–386. 52 indexed citations

19.

Iacovelli, Roberto, Maria Mancini, Emanuela Risi, Antonella Palazzo, & Enrico Cortesi. (2012). Genital and inguinal cutaneous toxicity in male and female patients treated with sunitinib. International Journal of Dermatology. 51(2). 221–222. 7 indexed citations

20.

Alesini, Daniele, Roberto Iacovelli, Antonella Palazzo, et al.. (2012). Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules. Oncology. 84(2). 92–99. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact